Multicenter questionnaire survey on patterns of care for elderly patients with esophageal squamous cell carcinoma by the Japan Esophageal Oncology Group

Yasuo Hamamoto, Yasunori Akutsu, Fumio Nagashima, Shuichi Hironaka, Yoshinori Ito, Ken Kato, Hiroki Hara, Yasuhiro Tsubosa, Satoru Nakagawa, Hiroyuki Daiko, Soji Ozawa, Yuukou Kitagawa

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Objective: There is little information about the patterns of care for elderly esophageal squamous cell carcinoma patients, and a standardized strategy has not been established. Therefore,we conducted a questionnaire survey about the patterns of care for these patients. Methods: On September 2014, the questionnaires were sent to all 43 institutions of the Japan Esophageal Oncology Group, which comprised five parts: (i) definition of 'elderly' (age, method), (ii) basic treatment strategy according to stage and elderly status (fit/vulnerable/frail), (iii) patterns of care in each stage, (iv) considerations about conducting future clinical trials and (v) other information about geriatric oncology concerning esophageal squamous cell carcinoma. Results: All answers were obtained by January 2015. Nearly half institutions (47%) considered the chronological definition of elderly to be over 80 years old. Among 43 institutions, 36 (84%) reported that the type of comorbidity and performance status were important factors for decision-making; no institution selected geriatric scale as an indicator. The most selected treatment strategy in fit healthy elderly patients was the same as the standard treatment of non-elderly patients. Radiation alonewas considered the main treatment for vulnerable and frail esophageal squamous cell carcinoma patients. Most of the institutions answered that clinical trials for the elderly are warranted. Most institutions (70%) chose Stage II/III (non-T4) esophageal squamous cell carcinoma as an important investigational target. Conclusions: Fit healthy elderly were considered the same as non-elderly patients, although there are no established treatment selection criteria. Radiation alone plays most important role in the treatment for vulnerable and frail esophageal squamous cell carcinoma patients. Stage II/III (non-T4) disease is attractive and warranted for future investigations.

Original languageEnglish
Article numberhyv183
Pages (from-to)111-115
Number of pages5
JournalJapanese Journal of Clinical Oncology
Volume46
Issue number2
DOIs
Publication statusPublished - 2016 Feb 1

Fingerprint

Patient Care
Japan
Geriatrics
Therapeutics
Clinical Trials
Radiation
Esophageal Squamous Cell Carcinoma
Surveys and Questionnaires
Patient Selection
Comorbidity
Decision Making

Keywords

  • Elderly
  • Esophageal squamous cell carcinoma
  • Questionnaire

ASJC Scopus subject areas

  • Oncology
  • Cancer Research
  • Radiology Nuclear Medicine and imaging

Cite this

Multicenter questionnaire survey on patterns of care for elderly patients with esophageal squamous cell carcinoma by the Japan Esophageal Oncology Group. / Hamamoto, Yasuo; Akutsu, Yasunori; Nagashima, Fumio; Hironaka, Shuichi; Ito, Yoshinori; Kato, Ken; Hara, Hiroki; Tsubosa, Yasuhiro; Nakagawa, Satoru; Daiko, Hiroyuki; Ozawa, Soji; Kitagawa, Yuukou.

In: Japanese Journal of Clinical Oncology, Vol. 46, No. 2, hyv183, 01.02.2016, p. 111-115.

Research output: Contribution to journalArticle

Hamamoto, Yasuo ; Akutsu, Yasunori ; Nagashima, Fumio ; Hironaka, Shuichi ; Ito, Yoshinori ; Kato, Ken ; Hara, Hiroki ; Tsubosa, Yasuhiro ; Nakagawa, Satoru ; Daiko, Hiroyuki ; Ozawa, Soji ; Kitagawa, Yuukou. / Multicenter questionnaire survey on patterns of care for elderly patients with esophageal squamous cell carcinoma by the Japan Esophageal Oncology Group. In: Japanese Journal of Clinical Oncology. 2016 ; Vol. 46, No. 2. pp. 111-115.
@article{d17e6dc72aba4a6d95c822716c3a99cb,
title = "Multicenter questionnaire survey on patterns of care for elderly patients with esophageal squamous cell carcinoma by the Japan Esophageal Oncology Group",
abstract = "Objective: There is little information about the patterns of care for elderly esophageal squamous cell carcinoma patients, and a standardized strategy has not been established. Therefore,we conducted a questionnaire survey about the patterns of care for these patients. Methods: On September 2014, the questionnaires were sent to all 43 institutions of the Japan Esophageal Oncology Group, which comprised five parts: (i) definition of 'elderly' (age, method), (ii) basic treatment strategy according to stage and elderly status (fit/vulnerable/frail), (iii) patterns of care in each stage, (iv) considerations about conducting future clinical trials and (v) other information about geriatric oncology concerning esophageal squamous cell carcinoma. Results: All answers were obtained by January 2015. Nearly half institutions (47{\%}) considered the chronological definition of elderly to be over 80 years old. Among 43 institutions, 36 (84{\%}) reported that the type of comorbidity and performance status were important factors for decision-making; no institution selected geriatric scale as an indicator. The most selected treatment strategy in fit healthy elderly patients was the same as the standard treatment of non-elderly patients. Radiation alonewas considered the main treatment for vulnerable and frail esophageal squamous cell carcinoma patients. Most of the institutions answered that clinical trials for the elderly are warranted. Most institutions (70{\%}) chose Stage II/III (non-T4) esophageal squamous cell carcinoma as an important investigational target. Conclusions: Fit healthy elderly were considered the same as non-elderly patients, although there are no established treatment selection criteria. Radiation alone plays most important role in the treatment for vulnerable and frail esophageal squamous cell carcinoma patients. Stage II/III (non-T4) disease is attractive and warranted for future investigations.",
keywords = "Elderly, Esophageal squamous cell carcinoma, Questionnaire",
author = "Yasuo Hamamoto and Yasunori Akutsu and Fumio Nagashima and Shuichi Hironaka and Yoshinori Ito and Ken Kato and Hiroki Hara and Yasuhiro Tsubosa and Satoru Nakagawa and Hiroyuki Daiko and Soji Ozawa and Yuukou Kitagawa",
year = "2016",
month = "2",
day = "1",
doi = "10.1093/jjco/hyv183",
language = "English",
volume = "46",
pages = "111--115",
journal = "Japanese Journal of Clinical Oncology",
issn = "0368-2811",
publisher = "Oxford University Press",
number = "2",

}

TY - JOUR

T1 - Multicenter questionnaire survey on patterns of care for elderly patients with esophageal squamous cell carcinoma by the Japan Esophageal Oncology Group

AU - Hamamoto, Yasuo

AU - Akutsu, Yasunori

AU - Nagashima, Fumio

AU - Hironaka, Shuichi

AU - Ito, Yoshinori

AU - Kato, Ken

AU - Hara, Hiroki

AU - Tsubosa, Yasuhiro

AU - Nakagawa, Satoru

AU - Daiko, Hiroyuki

AU - Ozawa, Soji

AU - Kitagawa, Yuukou

PY - 2016/2/1

Y1 - 2016/2/1

N2 - Objective: There is little information about the patterns of care for elderly esophageal squamous cell carcinoma patients, and a standardized strategy has not been established. Therefore,we conducted a questionnaire survey about the patterns of care for these patients. Methods: On September 2014, the questionnaires were sent to all 43 institutions of the Japan Esophageal Oncology Group, which comprised five parts: (i) definition of 'elderly' (age, method), (ii) basic treatment strategy according to stage and elderly status (fit/vulnerable/frail), (iii) patterns of care in each stage, (iv) considerations about conducting future clinical trials and (v) other information about geriatric oncology concerning esophageal squamous cell carcinoma. Results: All answers were obtained by January 2015. Nearly half institutions (47%) considered the chronological definition of elderly to be over 80 years old. Among 43 institutions, 36 (84%) reported that the type of comorbidity and performance status were important factors for decision-making; no institution selected geriatric scale as an indicator. The most selected treatment strategy in fit healthy elderly patients was the same as the standard treatment of non-elderly patients. Radiation alonewas considered the main treatment for vulnerable and frail esophageal squamous cell carcinoma patients. Most of the institutions answered that clinical trials for the elderly are warranted. Most institutions (70%) chose Stage II/III (non-T4) esophageal squamous cell carcinoma as an important investigational target. Conclusions: Fit healthy elderly were considered the same as non-elderly patients, although there are no established treatment selection criteria. Radiation alone plays most important role in the treatment for vulnerable and frail esophageal squamous cell carcinoma patients. Stage II/III (non-T4) disease is attractive and warranted for future investigations.

AB - Objective: There is little information about the patterns of care for elderly esophageal squamous cell carcinoma patients, and a standardized strategy has not been established. Therefore,we conducted a questionnaire survey about the patterns of care for these patients. Methods: On September 2014, the questionnaires were sent to all 43 institutions of the Japan Esophageal Oncology Group, which comprised five parts: (i) definition of 'elderly' (age, method), (ii) basic treatment strategy according to stage and elderly status (fit/vulnerable/frail), (iii) patterns of care in each stage, (iv) considerations about conducting future clinical trials and (v) other information about geriatric oncology concerning esophageal squamous cell carcinoma. Results: All answers were obtained by January 2015. Nearly half institutions (47%) considered the chronological definition of elderly to be over 80 years old. Among 43 institutions, 36 (84%) reported that the type of comorbidity and performance status were important factors for decision-making; no institution selected geriatric scale as an indicator. The most selected treatment strategy in fit healthy elderly patients was the same as the standard treatment of non-elderly patients. Radiation alonewas considered the main treatment for vulnerable and frail esophageal squamous cell carcinoma patients. Most of the institutions answered that clinical trials for the elderly are warranted. Most institutions (70%) chose Stage II/III (non-T4) esophageal squamous cell carcinoma as an important investigational target. Conclusions: Fit healthy elderly were considered the same as non-elderly patients, although there are no established treatment selection criteria. Radiation alone plays most important role in the treatment for vulnerable and frail esophageal squamous cell carcinoma patients. Stage II/III (non-T4) disease is attractive and warranted for future investigations.

KW - Elderly

KW - Esophageal squamous cell carcinoma

KW - Questionnaire

UR - http://www.scopus.com/inward/record.url?scp=84961675556&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961675556&partnerID=8YFLogxK

U2 - 10.1093/jjco/hyv183

DO - 10.1093/jjco/hyv183

M3 - Article

C2 - 26685320

AN - SCOPUS:84961675556

VL - 46

SP - 111

EP - 115

JO - Japanese Journal of Clinical Oncology

JF - Japanese Journal of Clinical Oncology

SN - 0368-2811

IS - 2

M1 - hyv183

ER -